Vaccines 2022, 10(5), 819; https://doi.org/10.3390/vaccines10050819 - 22 May 2022
Best Paper Award
Dear Colleagues,
The editorial team would like to congratulate the winners of the Vaccines 2022 Best Paper Award, who were chosen by a selection committee chaired by the Editor-in-Chief, Prof. Dr. Ralph A. Tripp. Following a review process by the Award Evaluation Committee, four winners were selected.
Two Reviews:
CHF 400 and a chance to publish a paper free of charge in Vaccines in 2024 after peer review.
An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives
By Alessio Facciolà, Giuseppa Visalli, Antonio Laganà and Angela Di Pietro
Vaccines 2022, 10(5), 819; https://doi.org/10.3390/vaccines10050819
Virus-like Particles as Preventive and Therapeutic Cancer Vaccines
By Anna Lucia Tornesello, Anna Lucia Tornesello, Franco M. Buonaguro, Maria Lina Tornesello and Luigi Buonaguro
Vaccines 2022, 10(2), 227; https://doi.org/10.3390/vaccines10020227
Two Articles:
CHF 500 and a chance to publish a paper free of charge in Vaccines in 2024 after peer review.
Evaluation of Transplacental Antibody Transfer in SARS-CoV-2-Immunized Pregnant Women
By Ching-Ju Shen, Yi-Chen Fu, Yen-Pin Lin, Ching-Fen Shen, Der-Ji Sun, Huan-Yun Chen and Chao-Min Cheng
Vaccines 2022, 10(1), 101; https://doi.org/10.3390/vaccines10010101
Therapeutic Effect of Subunit Vaccine AEC/BC02 on Mycobacterium tuberculosis Post-Chemotherapy Relapse Using a Latent Infection Murine Model
By Jinbiao Lu, Xiaonan Guo, Chunhua Wang, Weixin Du, Xiaobing Shen, Cheng Su, Yongge Wu and Miao Xu
Vaccines 2022, 10(5), 825; https://doi.org/10.3390/vaccines10050825
Please join us in congratulating the winners of the Vaccines 2022 Best Paper Award. We would also like to take this opportunity to thank all of our authors for your continued support of Vaccines.
Kind regards,
Vaccines Editorial Office
Vaccines Best Paper Award
Eligibility and Requirements
– Papers published in Vaccines from 1 January 2022 to 31 December 2022;– Open to all career levels;
– Both regular and Special Issue submissions will be considered.
Selection Criteria
The papers will be selected by the journal Award Committee according to the following criteria:– Scientific merit and broad impact;
– Originality of the research objectives and/or the ideas presented;
– Creativity of the study design or uniqueness of the approaches and concepts;
– Clarity of presentation;
– Citations and downloads.
Past Winners
Year:
Winner
An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives
Virus-like Particles as Preventive and Therapeutic Cancer Vaccines
Vaccines 2022, 10(2), 227; https://doi.org/10.3390/vaccines10020227 - 2 Feb 2022
Evaluation of Transplacental Antibody Transfer in SARS-CoV-2-Immunized Pregnant Women
Vaccines 2022, 10(1), 101; https://doi.org/10.3390/vaccines10010101 - 10 Jan 2022
Award Committee
Dr. Ralph Tripp
Chairman
Univ Georgia
Prof. Michael Bukrinsky
The George Washington University
Prof. Christian Napoli
Department of Medical surgical sciences and translational medicine - Sapienza University of Rome
Prof. Sara Louise Cosby
Queen's University Belfast
Dr. Yashdeep Phanse
University of Wisconsin-Madison
Winner
Acceptance of a COVID-19 Vaccine in Japan during the COVID-19 Pandemic
Vaccines 2021, 9(3), 210; https://doi.org/10.3390/vaccines9030210 - 3 Mar 2021
Willingness to Receive COVID-19 Vaccination in Japan
Vaccines 2021, 9(1), 48; https://doi.org/10.3390/vaccines9010048 - 14 Jan 2021
Nanomaterial Delivery Systems for mRNA Vaccines
Vaccines 2021, 9(1), 65; https://doi.org/10.3390/vaccines9010065 - 19 Jan 2021
Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines
Vaccines 2021, 9(4), 359; https://doi.org/10.3390/vaccines9040359 - 8 Apr 2021
